+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Global Antibacterial Drugs market set to grow to $48bn by 2024” says new Visiongain report

26 April 2019
Pharma

Visiongain has launched a new pharma report Global Antibacterial Drugs Market Report : Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others.

The demand for antibacterial drugs will continue as bacterial infections are among the most common diseases worldwide. However, strong efforts to restrict antibiotic prescribing in developed and emerging markets will not only reduce bacterial resistance but will also restrain growth. The development of novel therapies, on the other hand, will be driven by increased government investment and funding from other public bodies.

The lead analyst of the report commented "As with other sectors of the pharmaceutical industry, future antibacterial drug development will be driven by innovation from small bio pharmaceutical companies, Visiongain believes.

Many of the most novel products in the development pipeline have come from small companies targeting new treatment pathways or mechanisms of action. Increased demand and funding from governments for new antibacterial drugs will benefit these small companies over the coming 10 years."

Leading companies featured in the report include Adenium Biotech ApS, Allecra Therapeutics GmbH, AstraZeneca, Bayer, BioVersys AG, Eli Lilly. GlaxoSmithKline (GSK), Merck & Co., Novartis, Pfizer and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Retinal Gene Therapy Market

The global Retinal Gene Therapy market is projected to grow at a CAGR of 9.6% by 2034
26 July 2024

Read

HIV Drugs and Injectables Market

The global HIV Drugs & Injectables market is projected to grow at a CAGR of 4.6 % by 2034
24 July 2024

Read

Digital Twin Technology in Pharmaceutical Manufacturing Market

The global Digital Twin Technology in Pharmaceutical Manufacturing market is projected to grow at a CAGR of 31.3% by 2034
23 July 2024

Read

Specialty Pharma Market

The global Specialty Pharma market is projected to grow at a CAGR of 7.5% by 2034
22 July 2024

Read